Parenteral Nutrition market was valued at US$ 7.06 Bn. in 2022 and it is expected to reach US$ 10.55 Bn. by 2029 at a CAGR of 5.9% during the forecast period.Parenteral Nutrition Market Overview:
A type of nourishment that is injected directly into a vein such as protein, carbohydrate, fat, minerals and electrolytes, vitamins, and other trace elements, to patients who are unable to absorb adequate food through tube feeding formula or by mouth to maintain a healthy nutritional status in the body. The digestive system is not used in parenteral feeding. Getting the correct diet promptly can help patients avoid difficulties and play a vital role in their recovery.To know about the Research Methodology :- Request Free Sample Report The report has covered the market trends from 2018 to forecast the market through 2029. 2022 is considered a base year however 2022's numbers are on the real output of the companies in the market. Special attention is given to 2022 and the effect of lockdown on the demand and supply, and the impact of lockdown for the next two years on the market. Some companies have done well in lockdown also and specific strategic analysis of those companies is done in the report.
Parenteral Nutrition Market Dynamics:
The increasing frequency of malnutrition among children, particularly in developing and underdeveloped nations around the world, is expected to fuel demand for parenteral nutrition. Besides, the mandate for parenteral nutrition to uphold a balance of vitamin, lipid, amino acid, mineral, and other nutrient in body is driving the market in upward direction. Parenteral medication administration has the advantage of quick action and lower dose distribution, which minimizes a variety of negative effects caused by food imbalances, encouraging the growth of PN products. Diseases include esophageal cancer, head and neck cancer, Crohn's disease, gastric cancer, ulcerative colitis, and laryngeal cancer influence oral food consumption. Parenteral feeding is expected to grow increasingly popular as a result of its rising prevalence. Two key market restrictions are the significant risk of infection during administration and patients' greater preference for enteral nutrition. The ongoing COVID-19 pandemic has boosted the use of PN to give the body the necessary nourishment and fluids for a speedier and safer recovery. The growing preference for parenteral administration over enteral feeding among COVID-19 patients for meeting nutritional needs, enhancing nutrient absorption, and lowering infection risk is fueling market expansion. Furthermore, the growing use of these formulations among physicians for assisting patients in achieving their target nutrition intake, improving rehabilitation, and reducing hospital stays is supporting market expansion. In addition, new product launches by the top mket players are likely to boost the growth of the market in the forecast period. For example, Fresenius Kabi stated in December 2018 that Omegaven (fish oil triglycerides), an FDA-approved fish oil lipid emulsion, would be commercially available in the United States. The nutritional type is intended to provide fatty acids and calories to paediatric patients with cholestasis caused by parenteral feeding (PNAC).Parenteral Nutrition Market Segment Analysis:
The single-dose amino acid solution segment is anticipated to adhere to the growth of the Parenteral Nutrition Market. Single-dose amino acid solution accounted for 29.6 % of the market in 2022. This is due to the use of these items, as well as vitamins, dextrose, and trace minerals, to help the undernourished populace maintain a healthy weight. Additionally, the rising usage of amino acid solutions can be ascribed to the availability of solutions with fewer side effects, leading to improved patient outcomes and an influx of regulatory-approved solutions. Parenteral Lipid Emulsion plays a variety of physiological tasks that are critical to life. For decades in North America, soybean oil lipid emulsions have been the foundation of parenteral nutrition lipid formulations. The use of intravenous lipid emulsions in parenteral nutrition has reduced reliance on dextrose as a primary source of nonprotein calories while also preventing the clinical effects of the essential fatty acid shortage. Hence, Lipids Nutrition is likely to support the growth of the market.Parenteral Nutrition Market Regional Segment:
In 2022, North America had the greatest share of 41.7%. This is due to the availability of technologically advanced medical equipment, significant research expenditures by governmental bodies and commercial establishments in the healthcare industry, and alliances between universities, regulatory agencies, and the medical device business. One of the primary drivers for this market is the growing need for home health care products, as PN products are available in both clinical and home health care settings. The market is expected to be driven by the growing geriatric population, as well as the rising prevalence of chronic diseases such as cancer, gastrointestinal system disorders, and cardiovascular difficulties. The objective of the report is to present a comprehensive analysis of the Parenteral Nutrition Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Parenteral Nutrition Market dynamics, structure by analyzing the market segments and project the Parenteral Nutrition Market size. Clear representation of competitive analysis of key players by Grade, price, financial position, Grade portfolio, growth strategies, and regional presence in the Parenteral Nutrition Market make the report investor’s guide.Parenteral Nutrition Market Scope: Inquire before buying
Parenteral Nutrition Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 7.06 Bn. Forecast Period 2023 to 2029 CAGR: 5.9% Market Size in 2029: US $ 10.55 Bn. Segments Covered: by Nutrition Type Carbohydrates Parenteral Lipid Emulsion Single Dose Amino Acid Solution Trace Elements Vitamins & Minerals Parenteral Nutrition Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Parenteral Nutrition Market Key Players
1.Baxter 2. Grifols 3. S.A. 4. Allergan 5. Otsuka Pharmaceutical Factory, Inc. 6. Actavis Inc. 7. B. Braun Melsungen AG 8. Fresenius Kabi AG 9. ViforPharma 10.Sichuan Kelun Pharmaceutical Co., Ltd. 11.Pfizer Inc. (Hospira Inc.) 12.Aculife Healthcare 13.Anhui Medipharm Co., Ltd. 14.Amanta HealthcareFAQs:
1. What is the Parenteral Nutrition Market value in 2022? Ans: The Parenteral Nutrition Market value in 2022 was estimated as 7.06 Billion USD. 2. What is the Parenteral Nutrition Market growth? Ans: The Parenteral Nutrition Market is anticipated to grow with a CAGR of 5.9% in the forecast period and is likely to reach USD 10.55 Billion by the end of 2029. 3. Which Nutrition Type segment is expected to dominate the Parenteral Nutrition Market during the forecast period? Ans: Single-dose amino acid solution accounted for the largest share of 31.0%. This is attributed to the adoption of these products, along with vitamins, dextrose, and trace minerals, for maintaining weight equilibrium among the undernourished population. 4. Which region is expected to dominate the Parenteral Nutrition Market during the forecast period? Ans: North America dominated the parenteral nutrition market with a share of 41.7% in 2022. This is attributable to the high research expenditure by government agencies and private entities in the healthcare sector and the presence of technologically advanced medical devices
1.Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Technology 2.3.2. Primary Research 2.3.2.1. Data from Primary Technology 2.3.2.2. Breakdown of Primary Technology 3. Executive Summary: Parenteral Nutrition Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2022 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Parenteral Nutrition Market 3.4. Geographical Snapshot of the Parenteral Nutrition Market, By Manufacturer share 4. Parenteral Nutrition Market Overview, 2022-2029 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porter Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Grades 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Parenteral Nutrition Market 5. Supply Side and Demand Side Indicators 6. Parenteral Nutrition Market Analysis and Forecast, 2022-2029 6.1. Parenteral Nutrition Market Size & Y-o-Y Growth Analysis. 7. Parenteral Nutrition Market Analysis and Forecasts, 2022-2029 7.1. Market Size (Value) Estimates & Forecast By Nutrition Type, 2022-2029 7.1.1. Carbohydrates 7.1.2. Parenteral Lipid Emulsion 7.1.3. Single Dose Amino Acid Solution 7.1.4. Trace Elements 7.1.5. Vitamins & Minerals 8. Parenteral Nutrition Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2022-2029 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Parenteral Nutrition Market Analysis and Forecasts, 2022-2029 9.1. Market Size (Value) Estimates & Forecast By Nutrition Type, 2022-2029 9.1.1. Carbohydrates 9.1.2. Parenteral Lipid Emulsion 9.1.3. Single Dose Amino Acid Solution 9.1.4. Trace Elements 9.1.5. Vitamins & Minerals 10. North America Parenteral Nutrition Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Parenteral Nutrition Market Analysis and Forecasts, 2022-2029 11.1. Market Size (Value) Estimates & Forecast By Nutrition Type’s, 2022-2029 12. Canada Parenteral Nutrition Market Analysis and Forecasts, 2022-2029 12.1. Market Size (Value) Estimates & Forecast By Nutrition Type’s, 2022-2029 13. Mexico Parenteral Nutrition Market Analysis and Forecasts, 2022-2029 13.1. Market Size (Value) Estimates & Forecast By Nutrition Type’s, 2022-2029 14. Europe Parenteral Nutrition Market Analysis and Forecasts, 2022-2029 14.1. Market Size (Value) Estimates & Forecast By Nutrition Type’s, 2022-2029 15. Europe Parenteral Nutrition Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K Parenteral Nutrition Market Analysis and Forecasts, 2022-2029 16.1. Market Size (Value) Estimates & Forecast By Nutrition Type’s, 2022-2029 17. France Parenteral Nutrition Market Analysis and Forecasts, 2022-2029 17.1. Market Size (Value) Estimates & Forecast By Nutrition Type’s, 2022-2029 18. Germany Parenteral Nutrition Market Analysis and Forecasts, 2022-2029 18.1. Market Size (Value) Estimates & Forecast By Nutrition Type’s, 2022-2029 19. Italy Parenteral Nutrition Market Analysis and Forecasts, 2022-2029 19.1. Market Size (Value) Estimates & Forecast By Nutrition Type’s, 2022-2029 20. Spain Parenteral Nutrition Market Analysis and Forecasts, 2022-2029 20.1. Market Size (Value) Estimates & Forecast By Nutrition Type’s, 2022-2029 21. Sweden Parenteral Nutrition Market Analysis and Forecasts, 2022-2029 21.1. Market Size (Value) Estimates & Forecast By Nutrition Type’s, 2022-2029 22. CIS Countries Parenteral Nutrition Market Analysis and Forecasts, 2022-2029 22.1. Market Size (Value) Estimates & Forecast By Nutrition Type’s, 2022-2029 23. Rest of Europe Parenteral Nutrition Market Analysis and Forecasts, 2022-2029 23.1. Market Size (Value) Estimates & Forecast By Nutrition Type’s, 2022-2029 24. Asia Pacific Parenteral Nutrition Market Analysis and Forecasts, 2022-2029 24.1. Market Size (Value) Estimates & Forecast By Nutrition Type’s, 2022-2029 25. Asia Pacific Parenteral Nutrition Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Parenteral Nutrition Market Analysis and Forecasts, 2022-2029 26.1. Market Size (Value) Estimates & Forecast By Nutrition Type’s, 2022-2029 27. India Parenteral Nutrition Market Analysis and Forecasts, 2022-2029 27.1. Market Size (Value) Estimates & Forecast By Nutrition Type’s, 2022-2029 28. Japan Parenteral Nutrition Market Analysis and Forecasts, 2022-2029 28.1. Market Size (Value) Estimates & Forecast By Nutrition Type’s, 2022-2029 29. South Korea Parenteral Nutrition Market Analysis and Forecasts, 2022-2029 29.1. Market Size (Value) Estimates & Forecast By Nutrition Type’s, 2022-2029 30. Australia Parenteral Nutrition Market Analysis and Forecasts, 2022-2029 30.1. Market Size (Value) Estimates & Forecast By Nutrition Type’s, 2022-2029 31. ASEAN Parenteral Nutrition Market Analysis and Forecasts, 2022-2029 31.1. Market Size (Value) Estimates & Forecast By Nutrition Type’s, 2022-2029 32. Rest of Asia Pacific Parenteral Nutrition Market Analysis and Forecasts, 2022-2029 32.1. Market Size (Value) Estimates & Forecast By Nutrition Type’s, 2022-2029 33. Middle East Africa Parenteral Nutrition Market Analysis and Forecasts, 2022-2029 33.1. Market Size (Value) Estimates & Forecast By Nutrition Type’s, 2022-2029 34. Middle East Africa Parenteral Nutrition Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Parenteral Nutrition Market Analysis and Forecasts, 2022-2029 35.1. Market Size (Value) Estimates & Forecast By Nutrition Type’s, 2022-2029 36. GCC Countries Parenteral Nutrition Market Analysis and Forecasts, 2022-2029 36.1. Market Size (Value) Estimates & Forecast By Nutrition Type’s, 2022-2029 37. Egypt Parenteral Nutrition Market Analysis and Forecasts, 2022-2029 37.1. Market Size (Value) Estimates & Forecast By Nutrition Type’s, 2022-2029 38. Nigeria Parenteral Nutrition Market Analysis and Forecasts, 2022-2029 38.1. Market Size (Value) Estimates & Forecast By Nutrition Type’s, 2022-2029 39. Rest of ME&A Parenteral Nutrition Market Analysis and Forecasts, 2022-2029 39.1. Market Size (Value) Estimates & Forecast By Nutrition Type’s, 2022-2029 40. South America Parenteral Nutrition Market Analysis and Forecasts, 2022-2029 40.1. Market Size (Value) Estimates & Forecast By Nutrition Type’s, 2022-2029 41. South America Parenteral Nutrition Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Parenteral Nutrition Market Analysis and Forecasts, 2022-2029 42.1. Market Size (Value) Estimates & Forecast By Nutrition Type’s, 2022-2029 43. Argentina Parenteral Nutrition Market Analysis and Forecasts, 2022-2029 43.1. Market Size (Value) Estimates & Forecast By Nutrition Type’s, 2022-2029 44. Rest of South America Parenteral Nutrition Market Analysis and Forecasts, 2022-2029 44.1. Market Size (Value) Estimates & Forecast By Nutrition Type’s, 2022-2029 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Parenteral Nutrition Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Fiber Grades, and R&D Investment 45.2.2. New Grade Launches and Grade Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment, and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures, and Strategic Alliances/ Sales Agreements 45.3. Company Profile: Key Players 45.3.1. Pfizer 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Grade Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Baxter 45.3.3. Grifols 45.3.4. S.A. 45.3.5. Allergan 45.3.6. Otsuka Pharmaceutical Factory, Inc. 45.3.7. Actavis Inc. 45.3.8. Fresenius Kabi AG 45.3.9. ViforPharma 45.3.10. Sichuan Kelun Pharmaceutical Co., Ltd. 45.3.11. Pfizer Inc. (Hospira Inc.) 45.3.12. Aculife Healthcare 45.3.13. B. Braun Melsungen AG 45.3.14. Anhui Medipharm Co., Ltd. 45.3.15. Amanta Healthcare 46.Primary Key Insights